Antitrust
United States v. McKesson Corp., (2023)
Study notes for United States v. McKesson Corp.: professor notes, cold call prep, exam angles, and memory aids.
Engaging in price-fixing agreements between competitors is a violation of the Sherman Act.
In United States v. McKesson Corp., the court addressed the pivotal issues of price-fixing within the pharmaceutical distribution sector, underscoring the detrimental effects of collusive behavior on market competition and consumer welfare. The professor would emphasize the necessity of understanding the Sherman Act's prohibitions against agreements that restrain trade. McKesson’s case highlights how immediate competitors can collude to manipulate prices, affecting a vast array of entities from manufacturers to consumers.
MCK- Monitor Competition, Keep prices low
| Case | Distinction |
|---|---|
| United States v. Apple Inc. | In Apple, the focus was on vertical price-fixing in the ebook market rather than horizontal agreements among competitors. |
| Federal Trade Commission v. Sysco Corp. | Sysco involved market consolidation issues, rather than direct price-fixing conspiracies. |
Prohibiting price-fixing maintains competitive markets and protects consumer interests.
Strict enforcement may hinder legitimate collaborative efforts that could benefit consumers through innovation and lower prices.
This case is likely to appear on exams regarding the application of antitrust laws, particularly how the courts interpret collusive agreements under the Sherman Act. Students should be prepared to analyze fact patterns that might indicate price-fixing.